Corrigendum to “ASPP-092, a Curcuma comosa diarylheptanoid, inhibits the adipogenic differentiation of human bone marrow-derived mesenchymal stem cells via activation of TGF-β/SMAD2/3 signaling” (Biomedicine & Pharmacotherapy, (2025), 193, C, (118884), (S0753332225010789), 10.1016/j.biopha.2025.118884)

Sutjarit N.Yanukun K.Bhukhai K.Asavapanumas N.Rangketkarn S.Thongsa-ad U.Chaichompoo W.Suksamrarn A.Soodvilai S.Tantikanlayaporn D.Mahidol University2026-02-122026-02-122026-01-01Biomedicine and Pharmacotherapy (2026)07533322https://repository.li.mahidol.ac.th/handle/123456789/114944The Authors regret two errors in the original publication: A change is needed to the affiliation of an author, Sarun Rangketkarn, to:1.Master of Science Program in Nutrition, Faculty of Medicine Ramathibodi Hospital, and Institute of Nutrition, Mahidol University, Bangkok 10400, Thailand.2.The y-axis label in Fig. 8 contains an error. It should read “Relative Protein Expression.” In addition, the inhibitor name was misspelled and should read “SB431542.”. Master of Science Program in Nutrition, Faculty of Medicine Ramathibodi Hospital, and Institute of Nutrition, Mahidol University, Bangkok 10400, Thailand. The y-axis label in Fig. 8 contains an error. It should read “Relative Protein Expression.” In addition, the inhibitor name was misspelled and should read “SB431542.”. The authors would like to apologise for any inconvenience caused.Pharmacology, Toxicology and PharmaceuticsCorrigendum to “ASPP-092, a Curcuma comosa diarylheptanoid, inhibits the adipogenic differentiation of human bone marrow-derived mesenchymal stem cells via activation of TGF-β/SMAD2/3 signaling” (Biomedicine & Pharmacotherapy, (2025), 193, C, (118884), (S0753332225010789), 10.1016/j.biopha.2025.118884)ErratumSCOPUS10.1016/j.biopha.2026.1190302-s2.0-1050293014611950600741620346